HIV ATLAS

Social Media for HIV, TB & Malaria!

English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Belarusian Bulgarian Catalan Chinese (Simplified) Chinese (Traditional) Croatian Czech Danish Dutch Estonian Filipino Finnish French Galician Georgian German Greek Haitian Creole Hebrew Hindi Hungarian Icelandic Indonesian Irish Italian Japanese Korean Latvian Lithuanian Macedonian Malay Maltese Norwegian Persian Polish Portuguese Romanian Russian Serbian Slovak Slovenian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese Welsh Yiddish

Current strategies and limitations of HIV vaccines.

Current strategies and limitations of HIV vaccines. -
Current strategies and limitations of HIV vaccines.
Curr Opin Investig Drugs. 2010 Feb;11(2):192-202
Authors: Kawalekar OU, Shedlock DJ, Weiner DB
There is currently no cure for HIV infection, and the possibility of developing a vaccine in the near future appears unlikely. With more than 33 million individuals living with HIV/AIDS worldwide, there is a distinct need for a prophylactic vaccine against HIV infection. However, conventional vaccine strategies aimed at eliciting antibody and T-cell responses have failed to protect against the virus. Current research has been directed toward the more realistic goal of controlling viral replication during the early stages of infection, thus reducing the viral setpoint, through the use of novel vaccine delivery systems and techniques. In this review, several of the key milestones achieved as a result of research efforts aimed at developing an effective HIV vaccine are identified, and future prospects are examined.
PMID: 20112169 [PubMed - in process]
[PubMed-HIV]

By jenna - Posted on 01 February 2010 Share this

HIV ATLAS

Job Central

Classified Blogs

Event Central

Classified Ads

IEC Central

Videos

Resources

Monthly archive

Latest Jobs (Weekly)

Stay informed on our latest news!

Syndicate content

Classified Resources